Evidence map›Paper›PMID 41249608›Full record

ArticleLasers in medical science2025

Proposed treatment options for combined nevi: report of two cases using combination therapy involving surgical excision and laser therapy.

Kojiro Nagai, Yoshihisa Yamagi, Nobuyuki Mitsukawa

Abstract readCase Reports
In one paragraph

Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kojiro NagaiDepartment of Plastic, Reconstructive and Aesthetic Surgery, Faculty of Medicine, Chiba University, Chiba, Japan. kojiro.n1016@gmail.com.
Yoshihisa YamagiDepartment of Plastic, Reconstructive and Aesthetic Surgery, Faculty of Medicine, Chiba University, Chiba, Japan.
Nobuyuki MitsukawaDepartment of Plastic, Reconstructive and Aesthetic Surgery, Faculty of Medicine, Chiba University, Chiba, Japan. nmitsu@air.linkclub.or.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combined nevi are defined as the presence of 2 or more melanocytic cell groups within one lesion. They now refer to all cases of combinations of benign melanocytic nevus, including nevus cell nevi, Spitz nevi, and other melanocytic tumors, as well as blue nevi. In previous reports, treatment options for combined nevus primarily include surgical excision, laser therapy, cryotherapy, and combination therapy. However, there are no established guidelines for selecting the most appropriate treatment. A treatment for a combined nevus should be selected based on the histopathological structure of the combined nevus. On the other hand, laser therapy for combined nevi affects only blue nevus with melanocytosis and nevus spilus. Considering this background, we devise a treatment flowchart for a combined nevus against a blue nevus background. And we adapted this flowchart to two cases of combined nevus and underwent a combination therapy of excision and laser treatment, and neither case appeared to have any complications(e.g., postoperative hyperpigmentation, ectropion) and didn't recur. The combination therapy of surgical excision and laser treatment is one of the best treatments for combined nevus, considering the cosmetic aspect. We propose a treatment selection flowchart for combined nevus against a blue nevus background.

Indexed as

Laser TherapyNevus, BlueNevus, Epithelioid and Spindle CellNevus, PigmentedSkin NeoplasmsAdultCombined Modality TherapyFemaleHumansMaleCombination therapyCombined nevusLaser therapyQ-switched ruby laserSurgical excision

Identifiers

PMID41249608
PMCPMC12628369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.